key: cord-0864599-2wxvd9t2
authors: Jahan, Munira; Bhattacharjee, Arittra; Rahmat, Raad; Islam, S. M. Rashedul; Akhter, Tahmina; Ahammad, Ishtiaque; Hossain, Mohammad Uzzal; Munshi, Saif Ullah; Salimullah, M.
title: Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh
date: 2021-07-22
journal: Microbiology resource announcements
DOI: 10.1128/mra.00496-21
sha: cdfc144e1e0d3a4abd4554349ec1c96f2b493b54
doc_id: 864599
cord_uid: 2wxvd9t2

Mutations, deletions, and the emergence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may pose a serious health threat. Here, we report the genome sequences of SARS-CoV-2 viruses that were collected from SARS-CoV-2-infected patients during the end phase of the first wave of the COVID-19 pandemic in Dhaka, Bangladesh.

S evere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (family Coronaviridae, genus Betacoronavirus) is the causative agent of coronavirus disease 2019 . New variants of SARS-CoV-2 were detected as part of the second wave of the COVID-19 pandemic starting in March 2021 (https://www.worldometers.info/coronavirus/country/bangladesh/). Between November 2020 and February 2021, the rate of COVID-19 cases started to decrease and remained relatively low in Bangladesh. To analyze the types of SARS-CoV-2 variants which were circulating during the end phase of the first wave, nasopharyngeal swabs from SARS-CoV-2-infected patients were collected from the Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), during November and December 2020. (International, national, and/or institutional guidelines were followed according to the Institutional Review Board [IRB] of BSMMU; the ethical approval number is BSMMU/2020/ 6320.) Nasopharyngeal swabs were tested for SARS-CoV-2 RNA via real-time reverse transcription-PCR (RT-PCR), and 23 RT-PCR-positive samples (cycle threshold [Ct] , #25) were selected for the study.

Viral RNA was extracted from the nasopharyngeal samples using the QIAamp viral minikit (Qiagen; catalog number 52904). cDNA synthesis and library preparation were performed using the Illumina RNA prep kit with enrichment (catalog number 20040537) and IDT for Illumina DNA/RNA UD indexes (catalog number 20027213), followed by enrichment with the Respiratory Virus Oligos Panel v2 (Illumina; catalog number 20044311). All procedures were conducted according to the Illumina RNA prep with enrichment (L) tagmentation reference guide (1000000124435 v03). Sequencing was performed on the Illumina MiniSeq system. The genomes were then processed using the DRAGEN RNA pathogen detection app. The low-quality raw reads were trimmed using Trimmomatic v0.36, and the de novo genome assembly was performed using SPAdes v03. These steps were executed using default parameters (1, 2). In total, 23 contigs were obtained and compared with the SARS-CoV-2 isolate Wuhan-Hu-1 (GenBank accession number NC_045512.2); the genome coverage was 99.86% to 99.93%.

A phylogenetic tree was constructed as previously described (3) (Fig. 1 ). In short, the FASTA files of the assembled genome sequences were aligned using MAFFT (keeping the parameters unchanged), and the tree was created using FastTree v2.1. 10 (4, 5) via the Galaxy platform (6) . Here, SARS-CoV-2 isolate Wuhan-Hu-1 was used as the reference genome, and another lineage B.1.1.25 variant (hCoV-19/Bangladesh/BCSIR-NILMRC-356/2020jEPI_ISL_514129j2020-07-24) was added for comparison. The phylogenetic tree was visualized using iTOL (7) . All mutations were calculated using CoV-GLUE (8), with SARS-CoV-2 isolate Wuhan-Hu-1 used as the reference genome (Table 1) .

Finally, the SARS-CoV-2 genome sequences were uploaded to the Global Initiative on Sharing All Influenza Data (GISAID) database (9) and the Pangolin COVID-19 Lineage Assigner (10) . All viruses were from the B.1.1.25 lineage of the GR clade. Among them, P681R was the second most common mutation in the S gene (11 out of 23), after D614G, which has also been observed in the Indian lineages B.1.617.1, B.1.617.2, and B.1.617.3. A mutation in a similar position (P681H) was also detected in the UK variant B.1.1.7 (https://www.cdc.gov/). A mutation in P681 might affect the viral transmission and infectivity (11, 12) . This lineage was predominant during the peak of the first wave in Bangladesh (13); however, in the later stages, its spike glycoprotein (S) gained new mutations (Fig. 1) , which, with further changes, might help the virus escape humoral immunity in the near future and raise another surge of B.1.1.25-mediated COVID-19 cases. Therefore, continuous surveillance of this variant is necessary. 

N: R203K; N: G204R

N: R203K; N: G204R SRX11079876 hCoV-19/Bangladesh/BSMMU-19

ORF6: I60V; ORF7a: T14I; N: R203K

ORF3a: S171L

ORF6: I60V

SNP, single nucleotide polymorphism. b The raw reads are available in the NCBI Sequence Read Archive (SRA), and accession numbers are given for each library

SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing

Coding-complete genome sequence of SARS-CoV-2 isolate from Bangladesh by Sanger sequencing

MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization

FastTree 2: approximately maximumlikelihood trees for large alignments

The Galaxy platform for accessible, reproducible and collaborative biomedical analyses

Interactive Tree of Life (iTOL) v4: recent updates and new developments

CoV-GLUE: a Web application for tracking SARS-CoV-2 genomic variation

GISAID: global initiative on sharing all influenza data-from vision to reality

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Ten Hagen KG. 2021. Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation

A tale of three SARS-CoV-2 variants with independently acquired P681H mutations in New York State

Comparative genomic study for revealing the complete scenario of COVID-19 pandemic in Bangladesh

This study was funded by the Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. We also extend our gratitude to the Government of the People's Republic of Bangladesh for continuously supporting BSMMU regarding this endeavor of testing SARS-CoV-2 RNA using real-time RT-PCR since March 2020.